SNT 2.22% 4.4¢ syntara limited

Ann: Pharmaxis Drug Study Published in Nature Communications, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 127 Posts.
    lightbulb Created with Sketch. 5
    It will, another long runway whilst PXS looses money daily. Can you guess where that leads. All the Posters and articles dont put $ in the Bank Account. Any potential acquirer only has to wait or another Cap Raise to dilute again !
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.